Work Area: Litigation

Latest content

Building a robust trade secret strategy in China

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Life sciences companies should look to China’s recent legislation and court decisions as a framework to build a robust China IP strategy that integrates both patents and trade secrets.

24 June 2024

IP experts remain positive in the face of changes to the global life sciences landscape

AI, counterfeits and legislative overhauls are changing the game but contributors to the IAM Guide to Life Sciences offer strategic steps to help companies stay one step ahead

24 June 2024

Leveraging injunctive relief in pharmaceutical patent disputes in China

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Preliminary injunctions play a pivotal role in pharma patent infringement suits, serving as a crucial procedural tool for patentees to protect their IP rights. However, these offer significant advantages, pharma companies must exercise caution due to the risks associated with wrongful preservation.

24 June 2024

How to navigate the biosimilar and biologic markets amid challenging US litigation trends

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

A slew of recent litigation in the biologics and biosimilars space has drastically changed the landscape of this space and made it more challenging for biopharma companies and IP professionals.

24 June 2024

South Africa: Winning strategies to keep pace with evolving pharma sector

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

The South African pharmaceutical industry has grown substantially in recent years, while patent legislation has undergone significant divergence. Effective enforcement, prosecution and launch-to-market strategies require a keen understanding of the country’s IP and regulatory frameworks. 

24 June 2024

How to take advantage of both EPO prosecution and German enforcement

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Europe is one of the most important markets for the life sciences and pharma industry, and Germany is one of its key jurisdictions. Patenting life science inventions in Germany can be challenging as some biological subject matter is excluded from patent protection, so careful patent drafting is crucial in order to obtain allowable claims.

24 June 2024

Lenovo files another UPC counterattack – this time against Asustek

Chinese company is one of very few smartphone/computer companies asserting its patents at the Unified Patent Court

24 June 2024

It’s time to switch up patent case policies in the Western District of Texas

Saturday Opinion: Patent holders crave judges with experience and case progress predictability – and there’s a way to achieve it

22 June 2024

Interesting Alice issue arises in case where Amazon owes $122 million for ad tech infringement

Most of the time courts resolve patent eligibility issues pre-trial but here the jury decided the second prong on “inventive concept” – in the patent holder’s favour

21 June 2024

UPC grants Abbott a preliminary injunction – including for Ireland

But despite a couple of recent wins, PI applicants have a losing record at the Unified Patent Court

21 June 2024

Unlock unlimited access to all IAM content